Vaxcyte, Inc. (PCVX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$766.63M | -65.2% |
| 2024 | -$463.93M | -15.3% |
| 2023 | -$402.27M | -80.0% |
| 2022 | -$223.49M | -123.3% |
| 2021 | -$100.08M | -12.2% |
| 2020 | -$89.22M | -77.5% |
| 2019 | -$50.27M | -70.5% |
| 2018 | -$29.48M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$766.63M | -65.2% |
| 2024 | -$463.93M | -15.3% |
| 2023 | -$402.27M | -80.0% |
| 2022 | -$223.49M | -123.3% |
| 2021 | -$100.08M | -12.2% |
| 2020 | -$89.22M | -77.5% |
| 2019 | -$50.27M | -70.5% |
| 2018 | -$29.48M | — |